Bedrijfsvoering UCB

UCB

BE0003739530

Farmaceutische producten

Beurs gesloten - Euronext Bruxelles Andere beurzen 17:55:00 15-05-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
237,00 ^EUR	-1,37%		+1,24%	-0,67%

12/05	H Lundbeck verhoogt prognoses voor 2026 door Amerikaanse vraag en uitstel generieke concurrentie	RE
07/05	UCB kondigt nieuwe samenwerking aan om de ontwikkeling van nieuwe kankertherapieën te versnellen	AM

Uitvoerend comité: UCB

Bedrijfsleider

Beklede functiesVan

Jean-Christophe Tellier

67 jaar

Chief Executive Officer

01-01-2015

Sandrine Dufour

59 jaar

Director of Finance/CFO

01-07-2020

Antje Witte

Investor Relations Contact

Thomas Debeys

Comptroller/Controller/Auditor

Denelle Waynick

59 jaar

General Counsel

01-04-2023

Jean Fleurial

61 jaar

Human Resources Officer

01-09-2017

Xavier Michel

Corporate Secretary

01-06-2013

Raf Remijsen

Treasurer

01-03-2016

Alistair Henry

59 jaar

Chief Tech/Sci/R&D Officer

01-05-2024

Samenstelling van de raad van bestuur: UCB

Directeur

RadenVan

Jonathan Peacock

68 jaar

Audit Committee Chair

09-03-2023

Dame Davies

75 jaar

Compensation Committee Chair	15-03-2024
Governance Committee Chair	15-03-2024
Nominating Committee Chair	15-03-2024
Compensation Committee	01-03-2021
Nominating Committee	01-03-2021

Ulf Arne Wiinberg

67 jaar

Compensation Committee	15-03-2024
Governance Committee	15-03-2024
Nominating Committee	15-03-2024
Compensation Committee Chair	01-07-2017

Pierre Gurdjian

65 jaar

Compensation Committee
Governance Committee	28-04-2016
Nominating Committee
Finance Committee Chair

Charles-Antoine Janssen

55 jaar

Compensation Committee	15-03-2024
Governance Committee	15-03-2024
Nominating Committee	15-03-2024

Nefertiti Greene

55 jaar

Compensation Committee	25-04-2024
Governance Committee	25-04-2024
Nominating Committee	25-04-2024

Jean-Christophe Tellier

67 jaar

Executive Committee Chair

19-01-2015

Jonkheer Cédric van Rijckevorsel

56 jaar

Audit Committee

15-03-2024

Maëlys Castella

60 jaar

Audit Committee

01-01-2023

Cyril Janssen

55 jaar

Director/Board Member

01-01-2015

Jan Berger

69 jaar

Director/Board Member	01-04-2019
Independent Dir/Board Member	01-04-2019

Susan Gasser

71 jaar

Director/Board Member	01-01-2021
Independent Dir/Board Member	01-01-2021

Dolca Thomas

56 jaar

Director/Board Member	25-04-2024
Independent Dir/Board Member	25-04-2024

Recente benoemingen: UCB

26/04	Uitblinker Melexis kan Bel20 niet aan winst helpen	AM
21/04	Bavarian Nordic A/S keurt bestuursverkiezingen goed	CI
30/03	Sai Life Sciences Limited kondigt wijzigingen in het management aan	CI
27/03	Kay Davies stelt zich niet herkiesbaar als onafhankelijk bestuurder bij UCB	CI
10/03	H. Lundbeck A/S benoemt Markus Kede tot Senior Vice President en Chief AI Officer en treedt toe tot het Executive Leadership Team per 1 juli 2026	CI
21/01	Ocular Therapeutix, Inc. benoemt David W. Robinson tot Global Chief Commercial Officer	CI
18/12	Bavarian Nordic as benoemt Anne Louise Eberhard tot nieuwe voorzitter van de Raad van Bestuur	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: UCB

Insider

Beklede functies

VanTot

Albrecht de Graeve

Director/Board Member	29-04-2010	25-04-2024
Independent Dir/Board Member	29-04-2010	-

Iris Löw-Friedrich

Chief Tech/Sci/R&D Officer

01-03-2008

01-01-2024

Douglas James Gingerella

Comptroller/Controller/Auditor

01-09-2021

Pascale Richetta

Corporate Officer/Principal

15-01-2016

01-02-2020

Bharat Tewarie

Sales & Marketing

01-03-2015

01-02-2020

Anna Richo

General Counsel

01-11-2012

01-01-2019

Fabrice Enderlin

Human Resources Officer	01-03-2008	31-12-2017
Public Communications Contact	-	-

Ismail Kola

Chief Tech/Sci/R&D Officer

01-11-2009

31-12-2017

Harriet Edelman

Director/Board Member	01-01-2012	01-04-2017
Independent Dir/Board Member	01-01-2012	01-04-2017

Viviane Monges

Director/Board Member	01-04-2017	-
Independent Dir/Board Member	01-04-2017	-

Gerhard Mayr

Director/Board Member	01-01-2005	01-01-2017
Independent Dir/Board Member	01-01-2005	01-01-2017

Neil Weir

Corporate Officer/Principal

01-01-2017

Mark McDade

Chief Operating Officer	01-02-2015	01-10-2016
Corporate Officer/Principal	01-04-2008	01-02-2015

Thomas Fulton Wilson McKillop

Director/Board Member	01-01-2009	28-04-2016
Independent Dir/Board Member	01-01-2009	28-04-2016

Mohammed Khoso Baluch

Corporate Officer/Principal	01-02-2013	01-04-2016
Sales & Marketing	01-01-2008	01-04-2016

Alice Dautry-Varsat

Director/Board Member	01-01-2015	-
Independent Dir/Board Member	01-01-2015	-

Frederic Roch Doliveux

Director/Board Member	15-08-2011	31-12-2014
Chief Executive Officer	15-08-2011	31-12-2014
Director/Board Member	01-06-2017	01-01-2021

Peter John Fellner

Director/Board Member	01-01-2005	08-05-2014
Independent Dir/Board Member	14-09-2010	08-05-2014

Gregory Duncan

Corporate Officer/Principal

01-04-2007

01-02-2013

Karel Boone

Chairman

04-02-2010

30-04-2012

Gaëtan van de Werve

Director/Board Member

05-02-2010

26-04-2012

Thomas Leysen

Director/Board Member	01-01-2009	26-04-2012
Independent Dir/Board Member	20-05-2011	26-04-2012

Alexandre van Damme

Director/Board Member

14-09-2010

15-03-2012

Scott Myers

Corporate Officer/Principal

01-01-2007

01-09-2011

Michèle de Cannart

Corporate Officer/Principal

01-01-2000

01-06-2011

Fabrice Egros

Corporate Officer/Principal

01-09-2009

01-02-2011

Lorenz d'Este

Director/Board Member

22-02-2010

29-04-2010

Patrick Schwarz-Schütte

Director/Board Member

01-04-2009

Armand de Decker

Director/Board Member	01-01-2009	-
Independent Dir/Board Member	16-08-2011	-

Guy Keutgen

Director/Board Member

31-12-2008

Bill Robinson

Chief Operating Officer

31-12-2008

Alan John Blinken

Director/Board Member

31-12-2008

Jean-Louis Vanherweghem

Director/Board Member

31-12-2008

Sarah Howell

Corporate Officer/Principal

01-01-2004

01-07-2008

Nunzio Antonelli

Chief Tech/Sci/R&D Officer	01-06-2008	-
Corporate Officer/Principal	16-09-2010	14-02-2013

Jean-Pierre Kinet

Director/Board Member	01-01-2009	-
Independent Dir/Board Member	16-08-2011	-

Norman J. Ornstein

Director/Board Member	01-01-2008	-
Independent Dir/Board Member	01-01-2008	-

Richard Sachse

Corporate Officer/Principal

01-01-2007

Anthony G. Tebbutt

President

01-09-1996

01-10-2006

Detlef Thielgen

Director of Finance/CFO

01-01-2007

Inge Basteleurs

Director/Board Member	01-06-2011	-
General Counsel	01-06-2011	-
Corporate Secretary	01-06-2011	-

Frank Aranzana

Corporate Officer/Principal

01-01-1999

Georges Jacobs de Hagen

President

31-12-2004

Robert Trainor

General Counsel

05-02-2010

Luc Missorten

Director of Finance/CFO

01-01-2003

Laurent Lenoir

Corporate Officer/Principal

01-01-1991

01-01-2003

Jean-François Prost

Chief Tech/Sci/R&D Officer

01-01-2000

Jean M. Bellin

Corporate Officer/Principal

01-01-1993

01-01-1996

Jean van Rijckevorsel

Director/Board Member

01-01-1992

Piet Vanneste

Corporate Officer/Principal

01-01-1990

Evelyn du Monceau

Director/Board Member	01-01-1984	-
Chairman	-	-

Arnoud de Pret Roose de Calesberg

Director/Board Member

23-03-2011

Pol Vanderhaeghen

Corporate Officer/Principal

01-01-1973

Phee Wah Koh

Corporate Officer/Principal

Karen Stoddart

Corporate Officer/Principal

Nathalie Deldime

Public Communications Contact

Penelope Ward

Corporate Officer/Principal

Grahaem Brown

Corporate Officer/Principal

Arnaud Denis

Public Communications Contact

29-07-2009

Michel Mahy

Corporate Officer/Principal

O'Neill F. D'Cruz

Corporate Officer/Principal

Richard Simpson

Investor Relations Contact	16-08-2011	-
Public Communications Contact	09-02-2010	16-08-2011

Isabelle Ghellynck

Public Communications Contact

Malini Sundaram

Corporate Officer/Principal

Keith Bragman

Director/Board Member	-	-
Corporate Officer/Principal	-	-

Troy Cox

Corporate Officer/Principal

Gregory J. Dennis

Corporate Officer/Principal

Andrew J. McKnight

Chief Tech/Sci/R&D Officer

Iversen Bo

Comptroller/Controller/Auditor

Andre van der Toorn

Treasurer

Guy Wouters

Corporate Officer/Principal

Frank Coenen

Corporate Officer/Principal

Jan Vandendriessche

Chief Tech/Sci/R&D Officer

Michael Tuck-Sherman

Public Communications Contact

10-01-2011

Emmanuel Lacroix

Corporate Officer/Principal

12-03-2013

Jonathan W. Lewis

Corporate Officer/Principal

Gilles Capart

Chief Investment Officer

Donna M. Radzik

Corporate Officer/Principal

Emmanuel Janssen

Founder

18-01-1928

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	20
Vrouw	7

Waarvan leden van het uitvoerend comité

Man	6
Vrouw	3

Waarvan bestuurders

Man	11
Vrouw	2

Herzieningen

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Nee

Controverses sur les droits de l'Homme

Nee

Controverses Subventions fiscales

Nee

Conforme à la finance Islamique

UCB is een internationaal biofarmaceutisch bedrijf dat zich toelegt op het ontdekken en ontwikkelen van innovatieve geneesmiddelen en oplossingen om het leven te veranderen van mensen met ernstige ziekten van het immuunsysteem of van het centrale zenuwstelsel.

Werknemers

9.765

Sector

Farmaceutische producten

Agenda

Publicatie van de resultaten - Q2 2026

Meer informatie over het bedrijf